1-5 of 5
Syed S Ali
Close
Sort by
Journal Articles

Phase 1/2 Study of the Safety and Response of P-BCMA-101 CAR-T Cells in Patients with Relapsed/Refractory (r/r) Multiple Myeloma (MM) (PRIME) with Novel Therapeutic Strategies

Caitlin L. Costello, MD, Adam D. Cohen, MD, Krina K. Patel, MD, Syed S Ali, MD, Jesus G. Berdeja, MD, Nina Shah, MD, Siddhartha Ganguly, MD, Mehmet Hakan Kocoglu, MD, Mehrdad Abedi, MD, Eric M. Ostertag, MD PhD, Chris E Martin, PhD, Majid Ghoddussi, PhD, Devon J Shedlock, PhD, Joanne McCaigue, M.S., Hamid Namini, PhD, Sreeni Yalamanchili, Matthew A. Spear, MD, Tara K. Gregory, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 29–30.
https://doi.org/10.1182/blood-2020-142695
Published: 2020
Journal Articles

Experience and Outcome of Patients with Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL) over 8 Years

Syed S Ali, Reju George, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5352.
https://doi.org/10.1182/blood-2018-99-119613
Published: 2018
Journal Articles

Follicular Lymphoma Response with CDK4/6 Inhibitor(Palbociclib) Utilized in the Setting of Metastatic Breast Cancer

Syed S Ali, Wilson Mertens
Journal: Blood
Blood (2017) 130 (Supplement 1): 5165.
https://doi.org/10.1182/blood.V130.Suppl_1.5165.5165
Published: 2017
Journal Articles

Increasing Use of Social Media at Annual ASH Meetings

Saurabh Dahiya, MD, Ankit J. Kansagra, MD, Syed S. Ali, MBBS,
Journal: Blood
Blood (2015) 126 (23): 4469.
https://doi.org/10.1182/blood.V126.23.4469.4469
Published: 2015
Journal Articles

90Y-Ibtritumomab as a Single Agent for De Novo or Transformed Diffuse Large B Cell Lymphoma.

Syed S. Ali, MD, Gorusu Madhavi, MD, Kaplan Bruce, MD, Edwards L. Richard, MD, Joel Silver, MD, Stephen I. Firshein, MD, Syed Fazl Ali Bilgrami, MD
Journal: Blood
Blood (2007) 110 (11): 4505.
https://doi.org/10.1182/blood.V110.11.4505.4505
Published: 2007